Ishikawa Chie 石川千恵

… Alternative Names

ISHIKAWA Chie 石川千恵

Less

Researcher Number	90542358
Other IDs
Affiliation (Current)	2025: 琉球大学, 亜熱帯島嶼科学超域研究推進機構, 助教
Affiliation (based on the past Project Information) *help	2013 – 2019: 琉球大学, 亜熱帯島嶼科学超域研究推進機構, 助教
Review Section/Research Field	Principal Investigator Tumor biology
Keywords	Principal Investigator HTLV-1 / 成人T細胞白血病 / Tax / 発現制御 / シグナル伝達 / 癌 / ウイルス / Ivermectin / Importazole / 原発性体腔液性リンパ腫 … More / AP-1 / NF-κB / イベルメクチン / インポータゾル / インポーチン / c-myc / ISL-1 / 成人T細胞白血病（ATL） / インターフェロン調節因子(IRF)5 / 成人T細胞白血病・リンパ腫 / TNF-α / インターフェロン（IFN）調節因子(IRF)5 / 成人T細胞白血病・リンパ腫（ATLL） Less

Elucidation of pathogenesis and development of therapeutic strategy of adult T-cell leukemia with a focus on nuclear transport protein importinPrincipal Investigator
- Principal Investigator
  
  Ishikawa Chie
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor biology
- Research Institution
  University of the Ryukyus
The role of LIM homeodomain transcription factor ISL-1 in leukemogenesis in ATLPrincipal Investigator
- Principal Investigator
  
  ISHIKAWA Chie
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  University of the Ryukyus
Constitutive expression of interferon regulatory factor, IRF5 in HTLV-1-infected T cells.Principal Investigator
- Principal Investigator
  
  ISHIKAWA Chie
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  University of the Ryukyus

All 2020 2019 2018 2017 2016 2015 2013 Other

All Journal Article Presentation

[Journal Article] Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma2020
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori
- Journal Title
  
  European Journal of Pharmacology
  
  Volume: 872 Pages: 172953-172953
- DOI
  10.1016/j.ejphar.2020.172953
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines2018
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  Oncology Letters
  
  Volume: 15 Pages: 5311-5317
- DOI
  10.3892/ol.2018.7979
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Mitotic kinase PBK/TOPK as a therapeutic target for adult T-cell leukemia/lymphoma2018
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 53 Pages: 801-814
- DOI
  10.3892/ijo.2018.4427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Mitotic kinase PBK/TOPK as a therapeutic target for adult T-cell leukemia/lymphoma2018
- Author(s)
  Ishikawa Chie、Senba Masachika、Mori Naoki
- Journal Title
  
  International Journal of Oncology
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Anti-adult T-cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor2018
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 53 Pages: 1681-1690
- DOI
  10.3892/ijo.2018.4513
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma2017
- Author(s)
  Ishikawa Chie、Senba Masachika、Mori Naoki
- Journal Title
  
  International Journal of Oncology
  
  Volume: 51 Issue: 2 Pages: 633-643
- DOI
  10.3892/ijo.2017.4026
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida2017
- Author(s)
  Ishikawa Chie、Mori Naoki
- Journal Title
  
  Oncology Reports
  
  Volume: 38 Issue: 5 Pages: 3197-3204
- DOI
  10.3892/or.2017.5978
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.2017
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  Oncology Letters
  
  Volume: 印刷中
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K18414
[Journal Article] Expression and significance of Pim-3 kinase in adult T-cell leukemia2017
- Author(s)
  Ishikawa Chie、Senba Masachika、Hashimoto Tadashi、Imaizumi Atsushi、Mori Naoki
- Journal Title
  
  European Journal of Haematology
  
  Volume: 99 Issue: 6 Pages: 495-504
- DOI
  10.1111/ejh.12940
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K07175
[Journal Article] Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cel lines.2016
- Author(s)
  Chie Ishikawa, Takahiro Jomori, Junichi Tanaka, Masachika Senba, Naoki Mori.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 49 Issue: 4 Pages: 1713-1721
- DOI
  10.3892/ijo.2016.3648
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K18414
[Journal Article] Efficiency of AUY922 in mice with adult T-cell leukemia/lymphoma2016
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  Oncology Letters
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K18414
[Journal Article] Activation of PKC-δ in HTLV-1-infected T cells.2015
- Author(s)
  Mori N, Ishikawa C, Senba M.
- Journal Title
  
  Int J Oncol
  
  Volume: 46 Issue: 4 Pages: 1609-1618
- DOI
  10.3892/ijo.2015.2848
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592432, KAKENHI-PROJECT-25461428, KAKENHI-PROJECT-25830085
[Journal Article] Constitutive expression of IRF-5 in HTLV-1-infected T cells.2015
- Author(s)
  Chie Ishikawa, Masachika Senba, Betsy J. Barnes, Naoki Mori.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 印刷中
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25830085
[Journal Article] Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD302015
- Author(s)
  Chie Ishikawa, Masachika Senba, Naoki Mori.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 47 Issue: 6 Pages: 2197-2207
- DOI
  10.3892/ijo.2015.3218
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K18414, KAKENHI-PROJECT-25461428
[Journal Article] Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia2013
- Author(s)
  Naoki Mori, Chie Ishikawa, Jun-Nosuke Uchihara, Takeshi Yasumoto
- Journal Title
  
  Current Cancer Drug Targets
  
  Volume: VOL. 13 Issue: 8 Pages: 829-842
- DOI
  10.2174/156800961131300093
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461428, KAKENHI-PROJECT-25830085
[Journal Article] Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.2013
- Author(s)
  Ishikawa C, Tanaka J, Katano H, Senba M, Mori N.
- Journal Title
  
  Mar Drugs
  
  Volume: 11 Issue: 9 Pages: 3410-3423
- DOI
  10.3390/md11093410
- NAID
  120006986055
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592432, KAKENHI-PROJECT-25461428, KAKENHI-PROJECT-25830085
[Journal Article] Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB2013
- Author(s)
  Chie Ishikawa, Naoki Mori
- Journal Title
  
  International Journal of Oncology
  
  Volume: VOL. 42 Issue: 5 Pages: 1786-1792
- DOI
  10.3892/ijo.2013.1871
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461428, KAKENHI-PROJECT-25830085
[Journal Article] CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.2013
- Author(s)
  Ishikawa C, Kawakami H, Uchihara JN, Senba M, Mori N.
- Journal Title
  
  Biochem Biophys Acta - Molecular Cell Research (BBA-Mol Cell Res),
  
  Volume: 1833 Issue: 6 Pages: 1542-1552
- DOI
  10.1016/j.bbamcr.2013.03.006
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592432, KAKENHI-PROJECT-25461428, KAKENHI-PROJECT-25830085
[Presentation] 成人T細胞白血病の新規治療標的MALT12019
- Author(s)
  森直樹, 石川千恵
- Organizer
  第6回日本HTLV-1学会学術集会
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Importin β1 regulates cell growth and survival of KSHV-infected primary effusion lymphoma2019
- Author(s)
  Naoki Mori, Chie Ishikawa
- Organizer
  The 67th Annual Meeting of the Japanese Society for Virology
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] MALT1 as a novel therapeutic target for adult T-cell leukemia2019
- Author(s)
  Naoki Mori, Chie Ishikawa
- Organizer
  The 81st Annual Meeting of the Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] CUDC-907, a new dual PI3K and HDAC inhibitor, blocks multiple signaling pathways in primary effusion lymphoma2019
- Author(s)
  Naoki Mori, Chie Ishikawa
- Organizer
  The 78th Annual Meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] CUDC-907, a new dual PI3K and HDAC inhibitor, as ATL therapeutics.2018
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 77th Annual Meeting of the Japanese Cancer Association.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Evaluation of artesunate for the treatment of adult T-cell leukemia.2018
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 80th Annual Meeting of the Japanese Society of Hematology.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] 成人T細胞白血病の治療候補薬アルテスネイト.2018
- Author(s)
  森直樹, 石川千恵.
- Organizer
  第5回日本HTLV-1学会学術集会
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Evaluation of artesunate for the treatment of primary effusion lymphoma.2018
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 77th Annual Meeting of the Japanese Cancer Association.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] SENP1, a new molecular target for ATL therapy.2018
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 66th Annual Meeting of the Japanese Society for Virology.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] PBK is a therapeutic target for KSHV-related primary effusion lymphoma.2017
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 65th Annual Meeting of the Japanese Society for Virology.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] インポーチンを標的としたATL治療戦略.2017
- Author(s)
  森直樹, 石川千恵.
- Organizer
  第４回日本HTLV-1学会学術集会.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] PBK, a serin-threonin kinase, as a therapeutic target for Hodgkin’s lymphoma.2017
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 76th Annual Meeting of the Japanese Cancer Association.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Targeting importins for therapy in adult T-cell leukemia.2017
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 79th Annual Meeting of the Japanese Society of Hematology.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Importin as a therapeutic target for ATL.2017
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 76th Annual Meeting of the Japanese Cancer Association.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Anti-ATL activity of dual PI3K and HDAC inhibitor CUDC-907.2017
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 65th Annual Meeting of the Japanese Society for Virology.
- Data Source
  KAKENHI-PROJECT-17K07175
[Presentation] Mitotic kinase PBK/TOPK as a therapeutic target for ATL.2016
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 75th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Activity of the novel dual SYK/JAK kinase inhibitor cerdulatinib against ATL.2016
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 75th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Anti-ATL activity of cerdulatinib, a novel dual SYK/JAK kinase inhibitor.2016
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 64th Annual Meeting of the Japanese Society for Virology.
- Place of Presentation
  札幌コンベンションセンター（北海道札幌市）
- Year and Date
  2016-10-23
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Targeting mitotic kinase PBK/TOPK decreases growth and survival of HTLV-1-infected T-cell lines.2016
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 78th Annucal Meeting of the Japanese Society of Hematology.
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Effets of fucoidan against KSHV-related primary effusion lymphoma both in vitro and in vivo.2016
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 64th Annual Meeting of the Japanese Society for Virology.
- Place of Presentation
  札幌コンベンションセンター（北海道札幌市）
- Year and Date
  2016-10-23
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] ATLの新規治療標的分子PBK/TOPK2016
- Author(s)
  森直樹、石川千恵
- Organizer
  第3回日本HTLV-1学会学術集会
- Place of Presentation
  鹿児島県市町村自治会館（鹿児島県鹿児島市）
- Year and Date
  2016-08-26
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] ATLに選択的に発現しているPim-3を分子標的とした新たな治療法の開発2015
- Author(s)
  森直樹、石川千恵
- Organizer
  第2回日本HTLV-1学会学術集会
- Place of Presentation
  東京大学医科学研究所講堂（東京都港区）
- Year and Date
  2015-08-21
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Pim-3 kinase as a therapeutic target for ATL.2015
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 77th Annucal Meeting of the Japanese Society of Hematology.
- Place of Presentation
  石川県立音楽堂（金沢市）
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Inhibition of proliferation and survival of HTLV-1-infected T-cell lines by peridinin.2015
- Author(s)
  Naoki Mori, Chie Ishikawa, Jun-ichi Tanaka.
- Organizer
  The 63rd Annual Meeting of the Japanese Society for Virology.
- Place of Presentation
  福岡国際会議場（福岡市）
- Year and Date
  2015-11-22
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Activity of the novel dual PI3K/mTOR inhibitor BEZ235 against ATL.2015
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 74th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  名古屋国際会議場（名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Activity of the novel dual PI3K/mTOR inhibitor BEZ235 against ATL.2015
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  The 63rd Annual Meeting of the Japanese Society for Virology.
- Place of Presentation
  福岡国際会議場（福岡市）
- Year and Date
  2015-11-22
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] Pim-3 kinase as a therapeutic target for ATL.2015
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  The 74th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  名古屋国際会議場（名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K18414
[Presentation] HTLV-1感染T細胞株における恒常的IRF-5発現.2013
- Author(s)
  石川千恵, 森直樹．
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜）
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] PP2AはATLの治療標的分子か？2013
- Author(s)
  森直樹, 石川千恵.
- Organizer
  第６回HTLV-1研究会
- Place of Presentation
  東京大学医科学研究所講堂（東京）
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] HTLV-1感染T細胞株における恒常的IRF5発現.2013
- Author(s)
  石川千恵, 森直樹.
- Organizer
  第61回日本ウイルス学会学術集会
- Place of Presentation
  神戸国際会議場（神戸）
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia.2013
- Author(s)
  Mori N, Ishikawa C.
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  ロトイン札幌（札幌）
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] Epstein-Barr virus latent membrane protein-1- and CD30-incuced IκB-ζ
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] PKC-δ activation in HTLV-1-infected T cells.
- Author(s)
  Naoki Mori, Chie Ishikawa.
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場（大阪市）
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] フラボノイド類化合物ブテインの抗成人T細胞白血病効果
- Author(s)
  石川千恵、森直樹
- Organizer
  第62回日本ウイルス学会学術集会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-11-10 – 2014-11-12
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] Anti-adult T-cell leukemia effects of natural flavonoid, butein.
- Author(s)
  Chie Ishikawa, Naoki Mori.
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] フラボノイド類化合物ブテインの抗成人T細胞白血病効果
- Author(s)
  森直樹、石川千恵
- Organizer
  第1回日本HTLV-1学会学術集会
- Place of Presentation
  東京大学医科学研究所講堂（東京都港区）
- Year and Date
  2014-08-22 – 2014-08-24
- Data Source
  KAKENHI-PROJECT-25830085
[Presentation] EBウイルスLMP-1タンパク質によるNF-κB制御因子IκB-ζの発現誘導
- Author(s)
  森直樹、石川千恵
- Organizer
  第62回日本ウイルス学会学術集会
- Place of Presentation
  パシフィコ横浜（横浜市）
- Year and Date
  2014-11-10 – 2014-11-12
- Data Source
  KAKENHI-PROJECT-25830085

1. 森直樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 千馬正敬

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results

Ishikawa Chie 石川 千恵

ISHIKAWA Chie 石川 千恵

Research Projects

Research Products

Co-Researchers

Elucidation of pathogenesis and development of therapeutic strategy of adult T-cell leukemia with a focus on nuclear transport protein importinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of LIM homeodomain transcription factor ISL-1 in leukemogenesis in ATLPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Constitutive expression of interferon regulatory factor, IRF5 in HTLV-1-infected T cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mitotic kinase PBK/TOPK as a therapeutic target for adult T-cell leukemia/lymphoma2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mitotic kinase PBK/TOPK as a therapeutic target for adult T-cell leukemia/lymphoma2018

Author(s)

Journal Title

Data Source

[Journal Article] Anti-adult T-cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.2017

Author(s)

Journal Title

Data Source

[Journal Article] Expression and significance of Pim-3 kinase in adult T-cell leukemia2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cel lines.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficiency of AUY922 in mice with adult T-cell leukemia/lymphoma2016

Author(s)

Journal Title

Data Source

[Journal Article] Activation of PKC-δ in HTLV-1-infected T cells.2015

Author(s)

Journal Title

DOI

Data Source

Ishikawa Chie 石川千恵

ISHIKAWA Chie 石川千恵